Rare diseases
Investigational molecules
Locations
Study on Reducing Cardiovascular Disease in Type 1 Diabetes Patients Using Finerenone and Semaglutide
DenmarkStudy on the Effects of Empagliflozin, Pioglitazone, and Semaglutide for Patients with Type 2 Diabetes
DenmarkStudy on the Effect of Semaglutide in Patients with Type 1 Diabetes and Insulin Resistance
FranceStudy on Semaglutide and Low Energy Diet for Obesity in Adolescents Aged 12-17
NorwayStudy on the Safety and Effectiveness of Semaglutide for Non-Diabetic Patients with Acute Ischemic Stroke
DenmarkStudy on Semaglutide for Reducing Mucositis in Patients Undergoing High-Dose Chemotherapy with Stem Cell Transplantation
DenmarkStudy of Semaglutide for Treating Prediabetes in Women with Previous Gestational Diabetes
BelgiumStudy on the Safety and Effectiveness of Oral Semaglutide for Patients with High Blood Sugar After Kidney Transplantation
DenmarkComparison of dapagliflozin and oral semaglutide effectiveness in type 2 diabetes patients based on insulin resistance or secretion deficit
ItalyStudy on Semaglutide for Weight Control in Patients with Schizophrenia and High BMI Using Antipsychotics
NorwayEvaluation of Long-Term Efficacy and Safety of Tirzepatide Versus Intensified Conventional Care in Early Treatment of Type 2 Diabetes in Adults
CzechiaSemaglutide for reducing visceral fat in adults with HIV, BMI 25–30 kg/m2 and no diabetes: randomized trial with lifestyle intervention
ItalyTell us about your condition – we search every trial in Europe and connect you with the right site.
